HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration - Concepedia

Concepedia

Publication | Closed Access

HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

355

Citations

11

References

2012

Year

Michael Singer, Carl C. Awh, Srinivas R. Sadda, William R. Freeman, Andrew N. Antoszyk, Pamela Wong, Lisa Tuomi

Ocular DiseaseOpen-label Extension TrialOphthalmologyAge-related DiseasesChoroidal Neovascularization SecondaryAge-related Macular DegenerationNeovascularizationRadiation Oncology

References

	Year	Citations

Page 1